Antidote Treatment Nerve Agent Auto-Injector Tender in USA - 99090676

Procurement Summary

Country: USA

Summary: Antidote Treatment Nerve Agent Auto-Injector (Atnaa)

Deadline: 04 Apr 2024

Posting Date: 20 Mar 2024

Other Information

Notice Type: Tender

TOT Ref.No.: 99090676

Document Ref. No.: SPE2DP-23-R-0002

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description
Solicitation: SPE2DP-23-R-0002
Item: ANTIDOTE TREATMENT, NERVE AGENT, Automatic, Dual-Chamber, Pralidoxime Chloride Injection, 300 mg per mL, 2 mL, and Atropine Injection, 2.99 mg per mL, 0.7 mL
NSN: 6505-01-362-7427
Description:
The Defense Logistics Agency Troop Support has a requirement for the supply of Antidote Treatment Nerve Agent Auto-Injector (ATNAA). ATNAA shall be made in accordance with MPID Number 6 dated May 2, 2019.
The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1).
The Government does not intend to use Part 12 for this acquisition - per FAR 10.002(d)(2).
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a base year and four (4) one-year options. The quantities for the base year and each option year are a minimum of 225, 000 each and a maximum of 1, 000, 000 each.
Inspection/Acceptance at Origin
FOB Destination
Delivery Destination: Susquehanna, PA
Production Lead Time is 164 days after issuance date of the delivery order (DD1155).
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell ATNAA before award decision.
****************************************************************************
IMPORTANT NOTICES
Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, s...
Active Contract Opportunity Notice ID SPE2DP-23-R-0002 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE LOGISTICS AGENCY Major Command TROOP SUPPORT MEDICAL Office DLA TROOP SUPPORT

General Information

Contract Opportunity Type: Presolicitation (Original)

All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA

Original Published Date: Mar 20, 2024 07:52 am EDT

Original Response Date: Apr 04, 2024 11:59 pm EDT

Inactive Policy: 15 days after response date

Original Inactive Date: Apr 19, 2024

Initiative: None
Classification

Original Set Aside:

Product Service Code: 6505 - DRUGS AND BIOLOGICALS

NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Place of Performance: Philadelphia, PA 19111 USA

Documents

 Tender Notice